Form 4: Enhabit Inc. Executive Ronald Leroy Langham JR Reports Stock Transactions
SEC Form 4 Filing
EVP Clinical Excellence & Strategy, Ronald Leroy Langham JR, reports acquisition and disposition of Enhabit, Inc. stock on March 1, 2024.
Summary
- On March 1, 2024, Ronald Leroy Langham JR, EVP Clinical Excellence & Strategy at Enhabit, Inc., acquired 15,027 shares of common stock at a price of $8.81 per share.
- On the same day, Langham disposed of 634 shares of common stock at $8.81 per share.
- Following these transactions, Langham directly owns 57,164 shares of Enhabit, Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing. It simply reports stock transactions by an insider and doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel.
Stakeholder Impact
- The stock transactions may be of interest to shareholders as they provide insight into the actions of company leadership.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of stock acquisition and disposition. |
| 03/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.